Author name: groggles

Irreversible Electroporation Focal Therapy (NanoKnife) now shown to be a safe and effective treatment in selected patients.

A recent publication by Prof Stricker’s and Prof Emberton’s group in the journal Prostate Cancer and Prostate Diseases confirmed the safety of NanoKnife focal therapy in prostate cancer. Prof Stricker feels that this is a major advance in focal therapy as irreversible electroporation has significant potential advantages over all the other energy sources currently used […]

Irreversible Electroporation Focal Therapy (NanoKnife) now shown to be a safe and effective treatment in selected patients. Read More »

Accuracy and safety of MRI/US targeted biopsies confirmed

Prof Stricker now has perfected the technique of MR-ultrasound fusion biopsies using the safe transperineal technique but using the technology of MRI’s for accurate localisation. Using the Biojet system, Prof Stricker has perfected he technique of MR-ultrasound fusion biopsies, having now performed over 100. He confirmed that the MRI allows for accurate localisation. The procedure is

Accuracy and safety of MRI/US targeted biopsies confirmed Read More »

MRI Guided transperineal biopsy

Australia’s first targeted safe biopsy of the prostate. Prof Stricker is amongst the first in Australia to pursue transperineal MRI ultrasound-fusion guided biopsy into the prostate. This uses advances in MRI imaging, fused with ultrasound. He recently confirmed that this was the safest biospy technique. Prof Stricker went on to say that the MRI ultrasound-fusion

MRI Guided transperineal biopsy Read More »

Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre

Opened late last year by Prime Minister Gillard, The Kinghorn Cancer Centre is a joint venture between the Garvan Institute of Medical Research and St Vincent’s Hospital. Associate Professor Phillip Stricker was appointed Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre. In response to the $5.5 million dollars funding over four years, he

Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre Read More »

Nanoknife – the first case

The first case of Nanoknife treatment for prostate cancer was performed in late February. Dr Stricker said he was pleased with the outcome and welcomed a leading edge surgical technology that would allow yet another option when tailoring treatments for patients. In particular, he felt that that the Nanoknife procedure coould help minimise side-effects. Nanoknife

Nanoknife – the first case Read More »

Robotic surgery prevails

Dr Stricker performed just over 250 surgical cases in 2012, one of the largest series in Australasia. When asked about the breakdown between robotic and open, he said that as per previous years over 200 were robotic. Given the outcomes, he believes it wil continue as a favoured choice for surgical treatment. Dr Stricker has

Robotic surgery prevails Read More »